Authors:
McFarland, EJ
Borkowsky, W
Fenton, T
Wara, D
McNamara, J
Samson, P
Kang, MH
Mofenson, L
Cunningham, C
Duliege, AM
Sinangil, F
Spector, SA
Jimenez, E
Bryson, Y
Burchett, S
Frenkel, LM
Yogev, R
Gigliotti, F
Luzuriaga, K
Livingston, RA
Citation: Ej. Mcfarland et al., Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine, J INFEC DIS, 184(10), 2001, pp. 1331-1335
Authors:
Rothstein, EP
Anderson, EL
Decker, MD
Poland, GA
Reisinger, KS
Blatter, MM
Jacobson, RM
Mink, CM
Gennevois, D
Izu, AE
Sinangil, F
Langenberg, AGM
Citation: Ep. Rothstein et al., An acellular pertussis vaccine in healthy adults: safety and immunogenicity, VACCINE, 17(23-24), 1999, pp. 2999-3006
Authors:
VanCott, TC
Mascola, JR
Loomis-Price, LD
Sinangil, F
Zitomersky, N
McNeil, J
Robb, ML
Birx, DL
Barnett, S
Citation: Tc. Vancott et al., Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope, J VIROLOGY, 73(6), 1999, pp. 4640-4650